전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article

References

  1. Saenger EL. 1980. Manual on early medical treatment of possible radiation injury. Med. Phys. 7: 82-82.
    CrossRef
  2. Ramalho AT, Nascimento A. 1991. The fate of chromosomal aberrations in 137Cs-exposed individuals in the Goiânia radiation accident. Health Phys. 60: 67-70.
    Pubmed CrossRef
  3. Rosen EM, Day R, Singh VK. 2015. New approaches to radiation protection. Front. Oncol. 4: 381.
    Pubmed PMC CrossRef
  4. Maier P, Wenz F, Herskind C. 2014. Radioprotection of normal tissue cells. Strahlenther. Onkol. 190: 745-752.
    Pubmed CrossRef
  5. Johnke RM, Sattler JA, Allison RR. 2014. Radioprotective agents for radiation therapy: future trends. Future Oncol. 10: 2345-2357.
    Pubmed CrossRef
  6. Breen AP, Murphy JA. 1995. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18: 1033-1077.
    Pubmed CrossRef
  7. Slupphaug G, Kavli B, Krokan HE. 2003. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat. Res. 531: 231-251.
    Pubmed CrossRef
  8. Le Caër S. 2011. Water radiolysis: influence of oxide surfaces on H2 production under ionizing radiation. Water 3: 235-253.
    CrossRef
  9. Skov KA. 1984. The contribution of hydroxyl radical to radiosensitization: a study of DNA damage. Radiat. Res. 99: 502-510.
    Pubmed CrossRef
  10. Roots R, Chatterjee A, Chang P, Lommel L, Blakely E. 1985. Characterization of hydroxyl radical-induced damage after sparsely and densely ionizing irradiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 47: 157-166.
    Pubmed CrossRef
  11. Bucher N, Britten C. 2008. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br. J. Cancer 98: 523-528.
    Pubmed PMC CrossRef
  12. Santivasi WL, Xia F. 2014. Ionizing radiation-induced DNA damage, response, and repair. Antioxid. Redox Signal. 21: 251-259.
    Pubmed CrossRef
  13. Andersen MH, Becker JC, thor Straten P. 2005. Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat. Rev. Drug Discov. 4: 399-409.
    Pubmed CrossRef
  14. Koukourakis M. 2012. Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Br. J. Radiol. 85: 313-330.
    Pubmed PMC CrossRef
  15. Chatterjee A. 2013. Reduced glutathione: a radioprotector or a modulator of DNA-repair activity? Nutrients 5: 525-542.
    Pubmed PMC CrossRef
  16. Selim M, Saha A, Mukherjea KK. 2017. Protection of radiation induced DNA damage by a newly developed molybdenum complex. J. Radioanal. Nucl. Chem. 311: 189-193.
    CrossRef
  17. Peterson D, Bensadoun R-J, Roila F, Group EGW. 2011. Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Ann. Oncol. 22: 78-84.
    Pubmed PMC CrossRef
  18. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, et al. 2007. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109: 820-831.
    Pubmed CrossRef
  19. Poo H, Park C, Kwak MS, Choi DY, Hong SP, Lee IH, et al. 2010. New biological functions and applications of highmolecular-mass poly-γ-glutamic acid. Chem. Biodivers. 7: 1555-1562.
    CrossRef
  20. Shih L, Van Y-T. 2001. The production of poly-(γ-glutamic acid) from microorganisms and its various applications. Bioresour. Technol. 79: 207-225.
    CrossRef
  21. Choi J-C, Uyama H, Lee C-H, Sung M-H. 2015. In vivo hair growth promotion effects of ultra-high molecular weight poly-γ-glutamic acid from Bacillus subtilis (Chungkookjang). J. Microbiol. Biotechnol. 25: 407-412.
    Pubmed CrossRef
  22. Lee T-Y, Kim D-J, Won J-N, Lee I-H, Sung M-H, Poo H. 2014. Oral administration of poly-γ-glutamate ameliorates atopic dermatitis in Nc/Nga mice by suppressing Th2-biased immune response and production of IL-17A. J. Invest. Dermatol. 134: 704-711.
    Pubmed CrossRef
  23. Lee T-Y, Kim Y-H, Yoon S-W, Choi J-C, Yang J-M, Kim C-J, et al. 2009. Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect. Cancer Immunol. Immunother. 58: 1781.
    Pubmed PMC CrossRef
  24. Kim TW, Lee TY, Bae HC, Hahm JH, Kim YH, Park C, et al. 2007. Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity. J. Immunol. 179: 775-780.
    CrossRef
  25. Park C, Sung M-H. 2009. New bioindustrial development of high molecular weight of poly-gamma-glutamic acid produced by Bacillus subtilis (chungkookjang). Polym. Sci. Technol. 20: 440-446.
  26. Suh D. 1999. Cooperative binding interaction of ethidium with allosteric DNA. Exp. Mol. Med. 31: 151-158.
    Pubmed CrossRef
  27. Reichmann M, Rice S, Thomas C, Doty P. 1954. A further examination of the molecular weight and size of desoxypentose nucleic acid. J. Am. Chem. Soc. 76: 3047-3053.
    CrossRef
  28. Cai L, Cherian MG. 2003. Zinc-metallothionein protects from DNA damage induced by radiation better than glutathione and copper- or cadmium-metallothioneins. Toxicol. Lett. 136: 193-198.
    Pubmed CrossRef
  29. Paul SS, Selim M, Saha A, Mukherjea KK. 2014. Synthesis and structural characterization of dioxomolybdenum and dioxotungsten hydroxamato complexes and their function in the protection of radiation induced DNA damage. Dalton Trans. 43: 2835-2848.
    Pubmed CrossRef
  30. Vos O. 1992. Role of endogenous thiols in protection. Adv. Space Res. 12: 201-207.
    Pubmed CrossRef
  31. Prasad S, Srivastava S, Singh M, Shukla Y. 2009. Clastogenic effects of glyphosate in bone marrow cells of Swiss albino mice. J. Toxicol. 2009: 308985.
    Pubmed PMC CrossRef
  32. Sung MH, Park C, Kim CJ, Poo H, Soda K, Ashiuchi M. 2005. Natural and edible biopolymer poly-γ-glutamic acid: synthesis, production, and applications. Chem. Record 5: 352-366.
    CrossRef
  33. Buescher JM, Margaritis A. 2007. Microbial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries. Crit. Rev. Biotechnol. 27: 1-19.
    Pubmed CrossRef
  34. Capitani D, De Angelis A, Crescenzi V, Masci G, Segre A. 2001. NMR study of a novel chitosan-based hydrogel. Carbohydr. Polym. 45: 245-252.
    CrossRef

Related articles in JMB

More Related Articles

Article

Research article

J. Microbiol. Biotechnol. 2018; 28(4): 527-533

Published online April 28, 2018 https://doi.org/10.4014/jmb.1712.12016

Copyright © The Korean Society for Microbiology and Biotechnology.

Protection of Radiation-Induced DNA Damage by Functional Cosmeceutical Poly-Gamma-Glutamate

Yu-Jin OH 1, Mi-Sun KWAK 1 and Moon-Hee Sung 1*

Department of Bio and Fermentation Convergence Technology, BK21 PLUS Project, Kookmin University, Seoul 02707, Republic of Korea

Correspondence to:Moon-Hee  Sung
smoonhee@kookmin.ac.kr

Received: December 7, 2017; Accepted: January 22, 2018

Abstract

Poly-gamma-glutamate (γ-PGA), an anionic polymer of glutamic acid bonded by γ-amide linkages, is a very promising biodegradable polymer isolated from the Bacillus subtilis sp. Chungkookjang found in Korean fermented food. γ-PGA is useful in a wide range of industrial fields, such as food, cosmetics, and medicine as it is water-soluble, anionic, biodegradable, and edible. In this study, we compared the radioprotective effects of high-molecular-weight 3,000 kDa γ-PGA and reduced form of glutathione (GSH known as radioprotector) on DNA damage. Radiation-induced DNA damage was measured by decrease of fluorescence intensity after DNA bind with ethidium bromide (EtBr). All experiments were performed 60Co gamma (γ) radiation at 1252 Gy with 50% DNA damage. As the concentration of 0.33 μM-1.65 μM γ-PGA increased, DNA protection from radiation-induced damage also increased, with a maximum of 87% protection. On the other hand, DNA protection of GSH with increasing concentration was up to maximally 70%. In this study, we demonstrate that γ-PGA exhibited significant radioprotective effects against gamma irradiation.

Keywords: Poly-gamma-glutamate, radioprotective material, gamma radiation, DNA damage, DNA protection

Introduction

With the Fukushima nuclear accident in Japan in 2011 and increasing use of nuclear facilities and radiation therapies, public concern about radiation exposure has also strengthened interest in radioprotective agents [1, 2]. These agents prevent or reduce radiation exposure by removing or inactivating the free radicals produced by radiation [3]. In experimental and clinical studies, radioprotective agents have already been introduced as chemical or molecular therapeutic agents, such as amifostine, antioxidants (glutathione, genistein, etc.), palifermin, and cysteine [4, 5]. Radiation-induced DNA damage includes both direct and indirect actions. Direct action is when the radiation energy is directly absorbed by organic molecules (DNA, etc.) and causes changes (point mutations, DNA strand breaks, DNA crosslinks, and chromosome aberrations) [6, 7]. If not repaired, these changes can result in cellular damage or death [5]. Indirect action is when the water in cells is ionized and produces free radicals and peroxides that interact with the surrounding cellular components, causing metabolic disorders [6, 7]. All organisms consist of 70-85% water. Thus, exposing organisms or cells to radiation results in primary ionization of the water molecules, known as radiolysis, and the formation of free radicals, such as hydroxyl radicals, sub-excitation electrons, hydrogen peroxide, hydrogen atoms, hydrated electrons, and superoxides [8]. In particular, hydroxyl radicals produce the most DNA damage [9, 10]. Additionally, the DNA damage caused by free radicals generated by radiation includes biologically important cellular lesions (single-strand breaks, double-strand breaks, multiply damaged sites, base modifications, and adduct formation) [11, 12]. Moreover, when an organism is exposed to radiation, both direct and indirect actions are thought to occur at the same time, where direct action accounts for about 25%, while the remaining 75% is attributed to indirect action. Thus, the DNA damage caused by the free radicals and peroxides generated by the ionization of water molecules due to the indirect action of radiation is much more significant than the direct action of radiation, as the portion of intracellular DNA is very small [13].

Radioprotective agents are defined as substances that are capable of modifying harmful biological responses to radiation [14]. The reduced form of glutathione (GSH) is the tripeptide thiol, which consists of L-glutamine, cysteine, and glycine and is an endogenous scavenger of antioxidants. GSH acts as a hydrogen donor to hydroxyl radicals to prevent DNA strand breaks [15, 16]. Amifostine is the only radioprotective agent that has been approved for clinical use by the US FDA. Amifostine is a thiol derivative that acts as a free radical scavenger for radiation protection. However, the side effects of amifostine include acute hypotension, nausea, vomiting, and allergic reactions [17, 18]. Therefore, there is an important need to identify more effective radiation protection materials with fewer side effects.

Poly-gamma-glutamic acid (γ-PGA) is an anionic polypeptide in which D- and/or L-glutamate is polymerized via γ-amide linkages between the α-amino and γ-carboxylic acid functional groups [19, 20]. γ-PGA is also a very promising biodegradable polymer produced by Bacillus subtilis (Chungkookjang) [21]. As a microorganism, Bacillus subtilis is generally regarded as safe (GRAS) and is widely consumed as a food ingredient [22]. Moreover, in terms of attractive properties, γ-PGA is water soluble, anionic, biodegradable, and edible, which has resulted in a variety of applications, including cosmetics/skin care, bone care, nanoparticle for drug delivery systems, hydrogels, immune-stimulating agents, and pharmaceuticals [23-25].

Accordingly, this study demonstrates the radioprotective functions of high-molecular-weight γ-PGA (average molecular mass 3,000 kDa). When increasing the concentration of γ-PGA, the fluorescence intensity of an EtBr–DNA solution increased when compared with the DNA-irradiated control, indicating protection against radiation damage [16]. Thus, the results indicate that γ-PGA is a radioprotective agent and potential functional cosmeceutical material against gamma irradiation.

Materials and Methods

Materials

Calf thymus DNA (CT-DNA), a reduced form of GSH, and D-glutamic acid were all purchased from Sigma-Aldrich (USA). Ethidium bromide (EtBr) was purchased from Amresco (USA). L-Glutamic acid was purchased from Samchun (Korea). A BPE buffer (6 mM NaHPO4, 2 mM NaH2PO4, and 1 mM ethyl-enediaminetetraacetic acid disodium salt dehydrate, pH 7.0) was used for the experiments [26]. All other chemicals and reagents were of analytical grade.

Preparation of DNA Solution

The CT-DNA (20 mg) was dissolved in the BPE buffer (10 ml) and kept overnight in a refrigerator to obtain a homogenous DNA solution and avert thermal degradation [16]. A molar absorption coefficient of 6,600 M-1 cm-1 at 260 nm was estimated for the DNA concentration, which was expressed in base pairs using a spectrophotometer [27]. The concentration of the prepared stock CT-DNA solution was 6.86 × 10-3 (M) and the final concentration was 10-5 (M). Moreover, the 260/280 ratio of the CT-DNA was 1.8, indicating that the DNA was free of any contaminating proteins [16].

Preparation of GSH Solution

A stock solution of the reduced form of glutathione (GSH) at a concentration of 5.0 × 10-3 (M) was prepared in the BPE buffer, and then 10–60 μM of GSH was added to the CT-DNA to create a final GSH concentration of 10-5 M. CT-DNA damage was induced by gamma radiation to determine the damage protection by GSH [16].

Preparation of Ethidium Bromide Solution

A stock solution of 1.0 × 10-3 M ethidium bromide (EtBr) was dissolved in the BPE buffer, and 60 μM of the final EtBr concentration was added for maximal DNA binding [16].

Preparation of D/L-Glutamate Solution

1.36 × 10-1 M D-glutamate and 1.36 × 10-1 M L-glutamate were dissolved in the BPE buffer as stock solutions and titrated to pH 6.8, respectively. A D/L-glutamate solution was then prepared by mixing equal portions and titrated to pH 6.8.

Preparation of Poly-Gamma-Glutamate

The 3,000 kDa γ-PGA (BioLeaders Corporation, Korea) was dissolved in the BPE buffer to make a stock solution of 3.33 × 10-6 M and titrated to pH 6.8. The average molecular mass of γ-PGA is 3,000 kDa and its polydispersity is 4.6.

Gamma Irradiation

The gamma irradiation dose rate was 3,756 Gy/h up to a total dose of 3,756 Gy using a 60Co gamma-irradiation facility (point source AECL, IR-79; MDS Nordion International Co. Ltd., Canada) at the Korea Atomic Energy Research Institute (Korea).

Fluorescence Spectrometry

The fluorescence emission intensity of the samples was measured using a FS-2 fluorescence spectrometer (Scinco, Japan). Radiolyzed DNA damage produced a decreased fluorescence binding intensity with EtBr. Thus, the samples including radioprotector agents showed an increased fluorescence intensity when compared with the samples without radioprotector agents. Three different samples containing 60 μM CT-DNA in 1.5 ml polypropylene tubes were exposed to gamma irradiation. One sample without a radioprotector and the other two samples with an added radioprotector (10–60 μM GSH and 0.33, 0.66, 0.99, 1.33, or 1.65 μM γ-PGA) in the BPE buffer were irradiated by the gamma 60Co source using a total dose of 3,756 Gy and 1,252 Gy. The fluorescence intensity analyses were then performed immediately. A 1 mM EtBr fluorophore solution was added to the different samples, which were then incubated for 30 min at 37°C for maximal binding with the CT-DNA. Thereafter, the fluorescence spectra were obtained by emission excitation at 500 nm and scanning from 510 to 800 nm.

Results

Estimation of Radiation-Induced Damage to Calf Thymus DNA

Free radicals generated by radiation cause DNA damage, resulting in a decreased fluorescence intensity due to reduced binding with EtBr-DNA. Thus, a decreased fluorescence intensity indicates DNA damage by radiation. Several forms of DNA damage can contribute to a decreased fluorescence intensity, including strand breaks, base liberation, and base oxidation [28].

The CT-DNA irradiated by the gamma source at a dose of 3,756 Gy/h up to a total dose of 3,756 Gy was bound with EtBr and the fluorescence emission spectra were measured at 624 nm. The control was DNA-EtBr exposed to 0 Gy radiation. The fluorescence intensity decreased gradually when increasing the radiation dose (Fig. 1). The residual quantity of double-strand DNA following radiation exposure was measured using a dose-effect curve (Fig. 2), where (I–Ia)/(I0Ia) represents the radiation-induced DNA damage, Ia represents the fluorescence intensity of EtBr, I0 is the control (i.e., the fluorescence intensity of the DNA-EtBr exposed to 0 Gy radiation), and I is the fluorescence intensity of the EtBr–DNA exposed to radiation [29]. The dose effect curve in Fig. 2 is almost linear, indicating the DNA strand breakage induced by the radiation.

Figure 1. Fluorescence spectra of the EtBr–DNA complex when increasing the radiation dosage. a [EtBr] = 60.0 μM, b [EtBr] = 60.0 μM + [DNA] = 60.0 μM, and c–h EtBr–DNA when gradually increasing gamma radiation in increments of 626 Gy up to total dose of 3,756 Gy.

Figure 2. Dose–response relationship of DNA strand breaks induced by gamma irradiation with a total dose of 3,756 Gy. Ia: EtBr fluorescence intensity, I0: EtBr–DNA control fluorescence intensity; and I: EtBr–DNA irradiated sample fluorescence intensity.

The D50, representing the radiation dose that caused 50%DNA damage, was also measured using the dose-effect curve (Fig. 2). In this study, D50 was a single dose of 1,252 Gy, as the exposed DNA-EtBr showed a drastically reduced fluorescence intensity when compared with the control DNA-EtBr exposed to 0 Gy radiation [16].

Estimation of Radiation-Induced DNA Damage Protection by GSH

To protect the DNA from radiation-induced damage, 10–60 μM of a reduced form of GSH was added to the DNA solution prior to the radiation exposure. GSH was selected as it has already been confirmed as a radioprotective agent. When increasing the concentration of GSH, the fluorescence intensity of the EtBr-DNA solution increased when compared with the control DNA exposed to 0 Gy, thereby indicating protection against DNA damage (Fig. 3). Fig. 4 shows a graph of (I–Ia)/(I0Ia) vs. [GSH]/[CT-DNA]. The damage protection increased gradually when increasing the amount of GSH with 1,252 Gy. As a result, GSH was calculated to provide 70% protection from gamma radiation-induced DNA damage when compared with the control exposed to 0 Gy. Table 1 shows the gamma radiation-induced DNA damage protection by GSH and the molar ratio of [GSH]/[CT-DNA] [16].

Table 1 . GSH p rotection o f CT-DNA from gamma radiationinduced damage..

GSH concentration (μM)DNA concentration (μM)[GSH]/[DNA] (μM/μM)DNA protection (%)
10600.1751
200.3358
300.5059
400.6763
500.8365
601.0070


Figure 3. Fluorescence emission spectra of the EtBr-DNA complex when increasing the amount of GSH with a total gamma-irradiation dosage of 1,252 Gy. a [EtBr] = 60.0 μM only, b [EtBr] = 60.0 μM + [DNA] = 60.0 μM, c [EtBr] = 60.0 μM + [DNA] = 60.0 μM; with total gamma-irradiation dosage of 1,252 Gy, d 10.0 μM GSH, e 20.0 μM GSH, f 30.0 μM GSH, g 40.0 μM GSH, h 50.0 μM GSH, and i 60.0 μM GSH.

Figure 4. Plot of DNA protection vs. [GSH]/[DNA].

Estimation of Radiation-Induced DNA Damage Protection by Poly-Gamma-Glutamate

To protect the DNA from radiation-induced damage, 0.33, 0.66, 0.99, 1.33, or 1.65 μM of γ-PGA was added to the DNA solution prior to the radiation exposure. When increasing the concentration of γ-PGA, the fluorescence intensity of the EtBr-DNA solution increased when compared with the control DNA exposed to 0 Gy, indicating DNA damage protection, whereas D/L-glutamate, a monomer of γ-PGA, showed no radioprotective effects (Fig. 5). Fig. 6 shows a graph of (I–Ia)/(I0Ia) vs. [γ-PGA]/[CT-DNA]. The damage protection increased gradually when increasing the amount of γ-PGA with 1,252 Gy. As a result, γ-PGA was calculated to provide 87% protection from gamma radiation-induced DNA damage when compared with the control exposed to 0 Gy. Table 2 shows the gamma radiation-induced DNA damage protection by γ-PGA and the molar ratio of [γ-PGA]/[CT-DNA].

Table 2 . γ-PGA protection of CT-DNA from gamma radiationinduced damage..

γ-PGA concentration (μM)DNA concentration (μM)[γ-PGA]/[DNA] (μM/μM)DNA protection (%)
0.33600.00665
0.660.01176
0.990.01776
1.330.02282
1.650.02887


Figure 5. Fluorescence emission spectra of the EtBr-DNA complex when increasing the amount of γ-PGA with a total gamma-irradiation dosage of 1,252 Gy. a [EtBr] = 60.0 μM only, b [EtBr] = 60.0 μM + [DNA] = 60.0 μM, c [EtBr] = 60.0 μM + [DNA] = 60.0 μM; with a total gamma-irradiation dosage of 1,252 Gy, d 1.65 μM D/L-glutamate, e 0.33 μM γ-PGA, f 0.66 μM γ-PGA, g 0.99 μM γ-PGA, h 1.33 μM γ-PGA, and i 1.65 μM γ-PGA.

Figure 6. Plot of DNA protection vs. [γ-PGA]/[DNA].

Hence, the current results showed that γ-PGA produced a much greater increase of fluorescence intensity than GSH, indicating that γ-PGA also has a greater ability to protect against radiation-induced DNA damage.

Discussion

Many of the chemical changes in biomolecules (especially in DNA) are caused by free radicals, which are generated by mutagenic substances, including ionizing radiation, where the modifier produced by the radiation reaction has various biological effects [4, 5].

GSH as a single agent has already been shown to affect DNA damage and repair, redox regulation, and multiple cell signaling pathways. Additionally, as a major thiol compound in cells that scavenges OH• radicals, GSH has also been shown to play an important role in the conversion of DNA-derived peroxyl radicals into strand breaks [30]. Moreover, glutathione has been associated with preventing oxidative damage to the skin, and its role as a skin whitener was discovered as a side effect of large doses of glutathione [31].

γ-PGA is a biopolymer produced during the fermentation process by Bacillus subtilis, which is fundamental to the production of fermented soy sauce, such as natto (a traditional Japanese fermented food) and chonggukjang (a traditional Korean fermented food). Since these foods have been consumed for centuries, this is strong evidence supporting the safety of γ-PGA [21].

γ-PGA is an anionic, water-soluble, safe, and edible biomaterial naturally synthesized by Bacillus subtilis, in which the α-amino and γ-carboxy groups of glutamic acid are polymerized by a γ-amide linkage [32]. Moreover, the multi-functionalities of γ-PGA, such as its biodegradability, nontoxicity, compatibility, and edibility, have made it a promising biopolymer for use as a health food, thickener, osteoporosis-preventing factor, stabilizer in the food industry, moisturizer in cosmetics, and in various biomedical product applications [20, 32, 33].

In this study, the radioprotective effects of γ-PGA on DNA damage and the inhibition of damage after irradiation with a 60Co gamma source were characterized by fluorescence emission intensity measurements [16].

Free radicals generated by radiation cause DNA damage, resulting in a decreased fluorescence intensity due to reduced binding of EtBr-DNA. Thus, a decrease in the fluorescence intensity indicates DNA damage by radiation [28].

D50, representing the dose of radiation that damages 50% of the DNA, was also measured using a dose-effect curve (Fig. 2). In this study, a single dose of 1,252 Gy was determined as the D50, which drastically decreased the fluorescence intensity of the radiation-exposed DNA-EtBr compared with the control DNA-EtBr exposed to 0 Gy radiation.

When increasing the concentration of GSH, the DNA damage was gradually protected up to 70% owing to the presence of a thiol group, plus the fluorescence intensity of the EtBr-DNA solution increased compared with that of the control DNA exposed to 0 Gy (Fig. 3).

Meanwhile, Fig. 5 shows that increasing the concentration of γ-PGA also protected against DNA damage, as indicated by the increased fluorescence intensity of the EtBr-DNA solution when compared with that of the control DNA exposed to 0 Gy. Additionally, γ-PGA was calculated to provide 87% protection from gamma radiation-induced DNA damage when compared with the control exposed to 0 Gy. Thus, the high-molecular-weight 3,000 kDa γ-PGA produced a much greater increase of fluorescence intensity than GSH, indicating that γ-PGA also has a greater radioprotective efficiency against radiation-induced DNA damage [16].

This study also proposes the protection mechanism of poly-gamma-glutamate against radiation-induced DNA damage. Hydrogel is a semi-rigid jelly-like colloid, and most hydrogels contain more than 90% water by volume. The build-up of intramolecular bridges occurs for many reasons, including irradiation, repetitive freezing, and chemical cross-linkage. When exposed to gamma irradiation, water disintegrates and free radicals occurr in the γ-PGA solution. These free radicals correspond to the hydrogen in the main chain of the polymer, thereby providing reactive centers [32]. Thus, it is hypothesized that the hydroxyl radicals formed by gamma irradiation are the mechanism of a crosslink formation that captures the hydrogen in γ-PGA [34].

In summary, the current in vitro results showed that γ-PGA exhibited significant radioprotective effects against gamma irradiation. Thus, it is hoped that this protective ability of γ-PGA against DNA damage can be used for the development of new functional cosmeceutical materials.

Acknowledgments

This study was supported by 2017 research funding from Kookmin University, Korea, the Korean Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT), and Establishment of Infrastructure for Industrialization of Korean Useful Microbes (R0004073).

Conflict of Interest


The authors have no financial conflicts of interest to declare.

Fig 1.

Figure 1.Fluorescence spectra of the EtBr–DNA complex when increasing the radiation dosage. a [EtBr] = 60.0 μM, b [EtBr] = 60.0 μM + [DNA] = 60.0 μM, and c–h EtBr–DNA when gradually increasing gamma radiation in increments of 626 Gy up to total dose of 3,756 Gy.
Journal of Microbiology and Biotechnology 2018; 28: 527-533https://doi.org/10.4014/jmb.1712.12016

Fig 2.

Figure 2.Dose–response relationship of DNA strand breaks induced by gamma irradiation with a total dose of 3,756 Gy. Ia: EtBr fluorescence intensity, I0: EtBr–DNA control fluorescence intensity; and I: EtBr–DNA irradiated sample fluorescence intensity.
Journal of Microbiology and Biotechnology 2018; 28: 527-533https://doi.org/10.4014/jmb.1712.12016

Fig 3.

Figure 3.Fluorescence emission spectra of the EtBr-DNA complex when increasing the amount of GSH with a total gamma-irradiation dosage of 1,252 Gy. a [EtBr] = 60.0 μM only, b [EtBr] = 60.0 μM + [DNA] = 60.0 μM, c [EtBr] = 60.0 μM + [DNA] = 60.0 μM; with total gamma-irradiation dosage of 1,252 Gy, d 10.0 μM GSH, e 20.0 μM GSH, f 30.0 μM GSH, g 40.0 μM GSH, h 50.0 μM GSH, and i 60.0 μM GSH.
Journal of Microbiology and Biotechnology 2018; 28: 527-533https://doi.org/10.4014/jmb.1712.12016

Fig 4.

Figure 4.Plot of DNA protection vs. [GSH]/[DNA].
Journal of Microbiology and Biotechnology 2018; 28: 527-533https://doi.org/10.4014/jmb.1712.12016

Fig 5.

Figure 5.Fluorescence emission spectra of the EtBr-DNA complex when increasing the amount of γ-PGA with a total gamma-irradiation dosage of 1,252 Gy. a [EtBr] = 60.0 μM only, b [EtBr] = 60.0 μM + [DNA] = 60.0 μM, c [EtBr] = 60.0 μM + [DNA] = 60.0 μM; with a total gamma-irradiation dosage of 1,252 Gy, d 1.65 μM D/L-glutamate, e 0.33 μM γ-PGA, f 0.66 μM γ-PGA, g 0.99 μM γ-PGA, h 1.33 μM γ-PGA, and i 1.65 μM γ-PGA.
Journal of Microbiology and Biotechnology 2018; 28: 527-533https://doi.org/10.4014/jmb.1712.12016

Fig 6.

Figure 6.Plot of DNA protection vs. [γ-PGA]/[DNA].
Journal of Microbiology and Biotechnology 2018; 28: 527-533https://doi.org/10.4014/jmb.1712.12016

Table 1 . GSH p rotection o f CT-DNA from gamma radiationinduced damage..

GSH concentration (μM)DNA concentration (μM)[GSH]/[DNA] (μM/μM)DNA protection (%)
10600.1751
200.3358
300.5059
400.6763
500.8365
601.0070

Table 2 . γ-PGA protection of CT-DNA from gamma radiationinduced damage..

γ-PGA concentration (μM)DNA concentration (μM)[γ-PGA]/[DNA] (μM/μM)DNA protection (%)
0.33600.00665
0.660.01176
0.990.01776
1.330.02282
1.650.02887

References

  1. Saenger EL. 1980. Manual on early medical treatment of possible radiation injury. Med. Phys. 7: 82-82.
    CrossRef
  2. Ramalho AT, Nascimento A. 1991. The fate of chromosomal aberrations in 137Cs-exposed individuals in the Goiânia radiation accident. Health Phys. 60: 67-70.
    Pubmed CrossRef
  3. Rosen EM, Day R, Singh VK. 2015. New approaches to radiation protection. Front. Oncol. 4: 381.
    Pubmed KoreaMed CrossRef
  4. Maier P, Wenz F, Herskind C. 2014. Radioprotection of normal tissue cells. Strahlenther. Onkol. 190: 745-752.
    Pubmed CrossRef
  5. Johnke RM, Sattler JA, Allison RR. 2014. Radioprotective agents for radiation therapy: future trends. Future Oncol. 10: 2345-2357.
    Pubmed CrossRef
  6. Breen AP, Murphy JA. 1995. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18: 1033-1077.
    Pubmed CrossRef
  7. Slupphaug G, Kavli B, Krokan HE. 2003. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat. Res. 531: 231-251.
    Pubmed CrossRef
  8. Le Caër S. 2011. Water radiolysis: influence of oxide surfaces on H2 production under ionizing radiation. Water 3: 235-253.
    CrossRef
  9. Skov KA. 1984. The contribution of hydroxyl radical to radiosensitization: a study of DNA damage. Radiat. Res. 99: 502-510.
    Pubmed CrossRef
  10. Roots R, Chatterjee A, Chang P, Lommel L, Blakely E. 1985. Characterization of hydroxyl radical-induced damage after sparsely and densely ionizing irradiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 47: 157-166.
    Pubmed CrossRef
  11. Bucher N, Britten C. 2008. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br. J. Cancer 98: 523-528.
    Pubmed KoreaMed CrossRef
  12. Santivasi WL, Xia F. 2014. Ionizing radiation-induced DNA damage, response, and repair. Antioxid. Redox Signal. 21: 251-259.
    Pubmed CrossRef
  13. Andersen MH, Becker JC, thor Straten P. 2005. Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat. Rev. Drug Discov. 4: 399-409.
    Pubmed CrossRef
  14. Koukourakis M. 2012. Radiation damage and radioprotectants: new concepts in the era of molecular medicine. Br. J. Radiol. 85: 313-330.
    Pubmed KoreaMed CrossRef
  15. Chatterjee A. 2013. Reduced glutathione: a radioprotector or a modulator of DNA-repair activity? Nutrients 5: 525-542.
    Pubmed KoreaMed CrossRef
  16. Selim M, Saha A, Mukherjea KK. 2017. Protection of radiation induced DNA damage by a newly developed molybdenum complex. J. Radioanal. Nucl. Chem. 311: 189-193.
    CrossRef
  17. Peterson D, Bensadoun R-J, Roila F, Group EGW. 2011. Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Ann. Oncol. 22: 78-84.
    Pubmed KoreaMed CrossRef
  18. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, et al. 2007. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109: 820-831.
    Pubmed CrossRef
  19. Poo H, Park C, Kwak MS, Choi DY, Hong SP, Lee IH, et al. 2010. New biological functions and applications of highmolecular-mass poly-γ-glutamic acid. Chem. Biodivers. 7: 1555-1562.
    CrossRef
  20. Shih L, Van Y-T. 2001. The production of poly-(γ-glutamic acid) from microorganisms and its various applications. Bioresour. Technol. 79: 207-225.
    CrossRef
  21. Choi J-C, Uyama H, Lee C-H, Sung M-H. 2015. In vivo hair growth promotion effects of ultra-high molecular weight poly-γ-glutamic acid from Bacillus subtilis (Chungkookjang). J. Microbiol. Biotechnol. 25: 407-412.
    Pubmed CrossRef
  22. Lee T-Y, Kim D-J, Won J-N, Lee I-H, Sung M-H, Poo H. 2014. Oral administration of poly-γ-glutamate ameliorates atopic dermatitis in Nc/Nga mice by suppressing Th2-biased immune response and production of IL-17A. J. Invest. Dermatol. 134: 704-711.
    Pubmed CrossRef
  23. Lee T-Y, Kim Y-H, Yoon S-W, Choi J-C, Yang J-M, Kim C-J, et al. 2009. Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect. Cancer Immunol. Immunother. 58: 1781.
    Pubmed KoreaMed CrossRef
  24. Kim TW, Lee TY, Bae HC, Hahm JH, Kim YH, Park C, et al. 2007. Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity. J. Immunol. 179: 775-780.
    CrossRef
  25. Park C, Sung M-H. 2009. New bioindustrial development of high molecular weight of poly-gamma-glutamic acid produced by Bacillus subtilis (chungkookjang). Polym. Sci. Technol. 20: 440-446.
  26. Suh D. 1999. Cooperative binding interaction of ethidium with allosteric DNA. Exp. Mol. Med. 31: 151-158.
    Pubmed CrossRef
  27. Reichmann M, Rice S, Thomas C, Doty P. 1954. A further examination of the molecular weight and size of desoxypentose nucleic acid. J. Am. Chem. Soc. 76: 3047-3053.
    CrossRef
  28. Cai L, Cherian MG. 2003. Zinc-metallothionein protects from DNA damage induced by radiation better than glutathione and copper- or cadmium-metallothioneins. Toxicol. Lett. 136: 193-198.
    Pubmed CrossRef
  29. Paul SS, Selim M, Saha A, Mukherjea KK. 2014. Synthesis and structural characterization of dioxomolybdenum and dioxotungsten hydroxamato complexes and their function in the protection of radiation induced DNA damage. Dalton Trans. 43: 2835-2848.
    Pubmed CrossRef
  30. Vos O. 1992. Role of endogenous thiols in protection. Adv. Space Res. 12: 201-207.
    Pubmed CrossRef
  31. Prasad S, Srivastava S, Singh M, Shukla Y. 2009. Clastogenic effects of glyphosate in bone marrow cells of Swiss albino mice. J. Toxicol. 2009: 308985.
    Pubmed KoreaMed CrossRef
  32. Sung MH, Park C, Kim CJ, Poo H, Soda K, Ashiuchi M. 2005. Natural and edible biopolymer poly-γ-glutamic acid: synthesis, production, and applications. Chem. Record 5: 352-366.
    CrossRef
  33. Buescher JM, Margaritis A. 2007. Microbial biosynthesis of polyglutamic acid biopolymer and applications in the biopharmaceutical, biomedical and food industries. Crit. Rev. Biotechnol. 27: 1-19.
    Pubmed CrossRef
  34. Capitani D, De Angelis A, Crescenzi V, Masci G, Segre A. 2001. NMR study of a novel chitosan-based hydrogel. Carbohydr. Polym. 45: 245-252.
    CrossRef